Showing results (171-180 of 216) with videos related to
Sort By:
Pageof 22
Plos One|June 12, 2013
Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71Xing Wu, Qunying Mao, Xin Yao, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 20, 2025
Tumor Cell-Derived CXCL2 Potentiates Neutrophil-Mediated Antitumor Immunity by Inhibiting Cholesterol Biosynthesis in Hepatocellular CarcinomaXin Liu, Danli Yang, Qianqian Jiang, et al.Emerging Microbes & Infections|March 4, 2025
Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis BBei Jiang, Guiwen Guan, Kaitao Zhao, et al.Emerging Microbes & Infections|March 7, 2022
Characterization and distribution of HIV-infected cells in semenLin Gao, Yan-Mei Jiao, Ping Ma, et al.BMC Gastroenterology|January 4, 2026
HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patientsYandi Xie, Xiaojing Zhang, Xiaozhou Yang, et al.International Journal of Cancer|April 28, 2012
AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum markerJun Ma, Di-Xian Luo, Chenfei Huang, et al.Antiviral Research|November 22, 2025
Targeted inhibition of IGF2BP1 effectively suppresses HBV replication via an m6A-dependent mannerDeyao Li, Yuxin Song, Danjuan Lu, et al.Circulation. Arrhythmia and Electrophysiology|November 17, 2017
STABLE-SR (Electrophysiological Substrate Ablation in the Left Atrium During Sinus Rhythm) for the Treatment of Nonparoxysmal Atrial Fibrillation: A Prospective, Multicenter Randomized Clinical TrialBing Yang, Chenyang Jiang, Yazhou Lin, et al.Emerging Microbes & Infections|June 11, 2019
Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infectionYing Yan, Lena Allweiss, Danli Yang, et al.Apoptosis : an International Journal on Programmed Cell Death|May 24, 2013
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapyYihui Fan, Jin Cheng, Sanjeev A Vasudevan, et al.Pageof 22